Samsung Biologics proposed acquisition marks a decisive move to consolidate its position as a global contract development and manufacturing organization
Journals
Editor's Guest
Ensuring Excellent Mobile Connectivity for...
Technology in Cancer Care: A story of evolving...
Bringing Shop Floor to Manufacturer's palm:...
As global competition intensifies, Samsung is investing in talent, acquisitions, and infrastructure to stay ahead
Samsung is reportedly planning a $650 billion investment over the next decade to expand AI chip production, semiconductor…
Singapore's BIOBOT Surgical raises $15.4 million to expand US operations, advance robotic prostate cancer diagnosis, and…
SpaceX is creating pathways for shareholders to realize value without fully stepping into public markets just yet
Samsung expects the global chip shortage to last until 2028, secures long-term AI supply deals with major data centre operators,…
Samsung expands AI access by allowing DX Division employees to use ChatGPT, Google Gemini, and Claude with new safeguards and…
